semaglutide risks side effects for diabetes and obesity treatment is semaglutide safe for long

CV primary is a composite of cardiovascular death, non-fatal MI, non-fatal stroke, and heart-failure events

Such rigorous evaluations involved reviewing extensive clinical data, ensuring that the medication could provide substantial benefits for individuals struggling with obesity

For context, Zepbound and Wegovy are FDA-approved specifically for chronic weight management

Some providers recommend temporary caloric cycling, alternating between slightly higher and lower intake days, to prevent metabolic adaptation

It is a cause for awareness

Current Research & Clinical Trials Retatrutide is currently undergoing Phase 2 and Phase 3 clinical trials to evaluate its safety, efficacy, and long-term outcomes